RNAGADE Trademark

Trademark Overview

On Wednesday, February 24, 2021, a trademark application was filed for RNAGADE with the United States Patent and Trademark Office. The USPTO has given the RNAGADE trademark a serial number of 90545037. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, October 15, 2025. This trademark is owned by Renagade Therapeutics LLC. The RNAGADE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; medical and scientific research in the field of cancer treatment and diagnosis; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines, namely, RNA and DNA therapeutics; research and development services in the field of antibodies; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the field of nucleic acids, namely, RNA and DNA therapeutics for use in the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, muscular disorders, reproductive disorders, infectious diseases, blood disorders, sepsis, alopecia, and cognitive disorders; scientific re...
rnagade

General Information

Serial Number90545037
Word MarkRNAGADE
Filing DateWednesday, February 24, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, October 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements

Pseudo MarkRENAGADE RENEGADE
Goods and ServicesDesign, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; medical and scientific research in the field of cancer treatment and diagnosis; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines, namely, RNA and DNA therapeutics; research and development services in the field of antibodies; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the field of nucleic acids, namely, RNA and DNA therapeutics for use in the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, muscular disorders, reproductive disorders, infectious diseases, blood disorders, sepsis, alopecia, and cognitive disorders; scientific research in the field of inhibitory nucleic acids, protein-encoding nucleic acids and polypeptide-encoding nucleic acids; pharmaceutical research and development; product research and development; scientific research and development; vaccine research and development in the field of RNA and DNA therapeutics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRenagade Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWatertown, MA 02472
Party NameRenagade Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Wednesday, September 15, 2021NON-FINAL ACTION WRITTEN
Saturday, February 27, 2021NEW APPLICATION ENTERED
Wednesday, May 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 15, 2021ASSIGNED TO EXAMINER
Wednesday, September 15, 2021NON-FINAL ACTION E-MAILED
Wednesday, September 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 26, 2022FINAL REFUSAL WRITTEN
Wednesday, January 26, 2022FINAL REFUSAL E-MAILED
Wednesday, January 26, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, July 26, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, July 26, 2022EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, July 26, 2022JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, July 26, 2022EX PARTE APPEAL-INSTITUTED
Saturday, August 20, 2022ASSIGNED TO LIE
Saturday, August 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 22, 2022ACTION CONTINUING FINAL - COMPLETED
Monday, August 22, 2022ACTION DENYING REQ FOR RECON E-MAILED
Monday, August 22, 2022NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Wednesday, January 4, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, January 4, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, January 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 16, 2023EXPARTE APPEAL TERMINATED
Tuesday, February 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 20, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 20, 2023SOU EXTENSION 1 FILED
Friday, October 20, 2023SOU EXTENSION 1 GRANTED
Tuesday, October 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 20, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 9, 2024SOU EXTENSION 2 FILED
Tuesday, April 9, 2024SOU EXTENSION 2 GRANTED
Wednesday, April 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 4, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 24, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 24, 2024SOU EXTENSION 3 GRANTED
Wednesday, October 15, 2025ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 15, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, October 24, 2024SOU EXTENSION 3 FILED

Related Keywords

rnagade disorders research scientific field development medical diseases treatment namely therapeutics